Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109-Reference-Cited by-同舟云学术

Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109

Published:2012-03 Issue:3 Volume:79 Page:633-637
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Berglund Ryan K.,Tangen Catherine M.,Powell Isaac J.,Lowe Bruce A.,Haas Gabriel P.,Carroll Peter R.,Canby-Hagino Edith D.,deVere White Ralph,Hemstreet George P.,Crawford E. David,Thompson Ian M.,Klein Eric A.

Publisher

Elsevier BV

Subject

Urology

Reference14 articles.

1. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial;Bolla;Lancet,2002

2. Patterns of prostate cancer treatment by clinical stage and age;Meltzer;Am J Public Health,2001

3. Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis;Berglund;Urology,2006

4. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer;Loeb;Urology,2007

5. Radical prostatectomy for clinical stage T3a disease;Freedland;Cancer,2007

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review;Minerva Urology and Nephrology;2024-05

2. Develop prediction model to help forecast advanced prostate cancer patients’ prognosis after surgery using neural network;Frontiers in Endocrinology;2024-03-21

3. Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy;International Urology and Nephrology;2023-06-12

4. Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group;Clinical Genitourinary Cancer;2023-02

5. A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity;Neoplasia;2023-02